Shareholders’ Equity (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended			3 Months Ended	9 Months Ended
	Feb. 10, 2021	Dec. 09, 2020	Jan. 27, 2021	Jan. 26, 2021	Jan. 31, 2020	Mar. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Shareholders’ Equity (Details) [Line Items]
Preferred stock, shares authorized							100,000,000	100,000,000
Common stock, shares authorized							300,000,000	300,000,000
Common stock, shares outstanding							72,533,850
Additional purchase of securities, description	In addition, pursuant to the Second Offering Underwriting Agreement, the Company granted the Representative a 45-day option to purchase up to 847,058 additional shares of common stock to cover over-allotments in connection with the Second Offering, which the Representative exercised in full on February 11, 2021.			the Company granted the Representative a 45-day option to purchase up to 578,312 additional shares of common stock, and/or 578,312 additional First Offering Warrants, to cover over-allotments in connection with the First Offering, which the Representative partially exercised to purchase 578,312 Warrants on the First Offering Closing Date. For additional information on these First Offering Warrants, see Note 16 – Share-Based Compensation.
Gross proceeds received (in Dollars)	$ 27,600		$ 1,370
Gross proceeds deduction, percentage	8.00%		8.00%				8.00%
Representative warrants to purchase of shares of common stock	225,882		154,216
Common stock, par value (in Dollars per share)							$ 0.0001	$ 0.0001
Warrants to purchase shares of common stock	198,776
Description of consulting agreement					the Company entered into an agreement with a consultant to replace an existing consulting agreement between the consultant and the Company to allow the consultant to elect to take from 50% to 100% of its compensation in the form of common stock based on an agreed upon conversion calculation. Any difference between the amount due and the actual fair value of the shares issued in payment is recorded as general and administrative expense in the Company’s Condensed Consolidated Financial Statements. Common stock to be issued to the consultant will be paid on a quarterly basis. During the nine months ended September 30, 2021 and 2020, respectively, the Company issued 15,740 shares of its common stock with a fair value of $69 thousand and 55,032 shares of its common stock, with a fair value of $193 thousand to the consultant for services previously rendered.
Consultant payment of common stock		5,000
Fair value of amount (in Dollars)		$ 31
Common stock of vested								2,125
Common stock of expense (in Dollars)								$ 13
Remaining shares of vested						2,875
Additional recognized expense (in Dollars)						$ 18
Vendor [Member]
Shareholders’ Equity (Details) [Line Items]
Common stock, par value (in Dollars per share)							$ 4.15
Warrants [Member]
Shareholders’ Equity (Details) [Line Items]
Warrants issued							100,000
First Offering [Member]
Shareholders’ Equity (Details) [Line Items]
Sale of aggregate units of shares				3,855,422
Public price per share (in Dollars per share)				$ 4.15
Common stock exercise price (in Dollars per share)				$ 4.5
Gross proceeds received (in Dollars)							$ 16,000
Purchase of additional shares of common stock			329,815
Sale of common stock, percentage							4.00%
Total expenses of public offering (in Dollars)							$ 2,700
Second Offering [Member]
Shareholders’ Equity (Details) [Line Items]
Sale of aggregate units of shares	5,647,059
Sale of common stock, percentage	4.00%
Total expenses of public offering (in Dollars)	$ 2,600
Sale of stock, price per unit (in Dollars per share)	$ 4.25
Private Placement [Member]
Shareholders’ Equity (Details) [Line Items]
Warrants to purchase shares of common stock	27,106